The top 50 drugs by frequency of positive signals stratified by sex – by 4 methods (ROR PRR IC MGPS).

The top 50 drugs by frequency of positive signals stratified by sex – by 4 methods (ROR PRR IC MGPS).

<p>Note: The odds ratios (OR) depicted in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0334500#pone.0334500.g003" target="_blank">Fig 3</a> are specifically pertinent to cases of acute respiratory distress syndrome (ARDS) and should not...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Jun Hua Lai (22676523) (author)
Outros Autores: Yi Ping Pan (22676526) (author), Zhi Hui Yu (22676529) (author), Wen Fang Jang (22676532) (author), Jun Tao Hu (22676535) (author), Zhan Hong Tang (22676538) (author)
Publicado em: 2025
Assuntos:
Cell Biology
Pharmacology
Biotechnology
Science Policy
Mental Health
Infectious Diseases
reporting odds ratio
increased vascular permeability
elucidating risk factors
compromised gas exchange
86 %), followed
study analyzed data
identify ade signals
prr ), chi
drug nomenclature using
reported ards population
patients requiring hospitalization
onset analysis demonstrated
induced adverse events
enhance patient safety
ades occurred within
term outcomes associated
median onset time
first 30 days
xlink "> drug
xlink ">
patient safety
study highlights
severe outcomes
median age
induced ards
first quarter
adverse event
ade management
ic ),
ebgm ),
drug dictionaries
drug administration
united states
underlying mechanisms
timely intervention
targeted ades
substantial implications
significant morbidity
reports originated
regulatory activities
pulmonary edema
prior studies
medical dictionary
information component
inflammatory cascades
future research
fourth quarter
findings revealed
endothelial dysfunction
disproportionality analyses
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
Descrição
Resumo:<p>Note: The odds ratios (OR) depicted in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0334500#pone.0334500.g003" target="_blank">Fig 3</a> are specifically pertinent to cases of acute respiratory distress syndrome (ARDS) and should not be extrapolated to encompass all adverse events analyzed in this study.</p>

Registos relacionados